Anil K. Rustgi, MD, a preeminent cancer physician-scientist, has been appointed Director of the Herbert Irving Comprehensive Cancer Center, and Chief of the Cancer Service, NYP/Columbia, and Irving Professor of Medicine and Associate Dean of Oncology at Columbia University.

The NCI’s Outstanding Investigator Awards were created to support leaders in cancer research who are developing applications that may lead to major breakthroughs.

As the Adult Blood and Marrow Transplant Program at NewYork-Presbyterian/Columbia continues to expand, clinicians are investigating new treatment approaches ranging from autologous to allogeneic and haplo-identical transplantation.

Lisa A. Newman, an internationally renowned breast surgeon and researcher, joined NewYork-Presbyterian/Weill Cornell Medical Center as Chief of Breast Surgery and Chief of the Interdisciplinary Breast Program.

In a study published in the December 11, 2015 issue of Science, Lewis C. Cantley and his team reported that high doses of vitamin C impaired the growth of KRAS mutant and BRAF mutant colorectal tumors.

These highly prestigious and competitive awards will encourage and support the best young physician-scientists in pursuing research aimed at improving the practice of cancer medicine.

The Center is focused on pursuing groundbreaking research and providing advanced treatments for glioblastoma and other deadly brain cancers.

Columbia’s Central Nervous System Metastases Clinic (CNSMets) was recently established to coordinate and advance the treatment of brain, leptomeningeal, skull base, spinal cord, and spine metastases.